Cefamandole nafate therapy in the treatment of acute urinary tract infections

Cefamandole nafate, a new cephalosporin antibiotic, was used to treat acute urinary tract infection in 31 patients, of whom 26 had pyelonephritis and 5 had cystitis. Eleven of these patients had underlying diseases or complicating factors present which frequently alter clinical response to therapy....

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 1976-12, Vol.2 (4), p.345-350
Main Authors: Short, H. D., Gentry, L. O., Sessoms, S.
Format: Article
Language:English
Subjects:
Acute Disease
Adolescent
Adult
Aged
Cefamandole - administration & dosage
Cefamandole - blood
Cefamandole - therapeutic use
Cephalosporins - therapeutic use
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Time Factors
Urinary Tract Infections - drug therapy
Urinary Tract Infections - etiology
Urinary Tract Infections - microbiology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cefamandole nafate, a new cephalosporin antibiotic, was used to treat acute urinary tract infection in 31 patients, of whom 26 had pyelonephritis and 5 had cystitis. Eleven of these patients had underlying diseases or complicating factors present which frequently alter clinical response to therapy. Relapse or reinfection occurred with equal frequency in both complicated and uncomplicated groups.
ISSN:0305-7453
1460-2091
DOI:10.1093/jac/2.4.345